Palgon AG
Avemio AG does not have significant operations. It intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. The company was founded in 2018 and is based in Frankfurt am Main, Germany.
Palgon AG (3D6) - Net Assets
Latest net assets as of June 2022: €160.11K EUR
Based on the latest financial reports, Palgon AG (3D6) has net assets worth €160.11K EUR as of June 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€169.74K) and total liabilities (€9.63K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €160.11K |
| % of Total Assets | 94.33% |
| Annual Growth Rate | -17.23% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 24.49 |
Palgon AG - Net Assets Trend (2019–2021)
This chart illustrates how Palgon AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Palgon AG (2019–2021)
The table below shows the annual net assets of Palgon AG from 2019 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | €167.87K | +10.79% |
| 2020-12-31 | €151.52K | -38.19% |
| 2019-12-31 | €245.12K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Palgon AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7725193.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €300.00K | 178.71% |
| Total Equity | €167.87K | 100.00% |
Palgon AG Competitors by Market Cap
The table below lists competitors of Palgon AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kwang Dong Pharmaceutical Co. Ltd.
KQ:009290
|
$58.17K |
|
GBK Beteiligungen AG
HM:GBQ
|
$58.25K |
|
Bloomsbury Publishing Plc
LSE:BMY
|
$58.26K |
|
AEM
AT:AEM
|
$58.27K |
|
P.V. Nano Cell Ltd
PINK:PVNNF
|
$58.09K |
|
Viromed Medical AG
DU:Q11
|
$58.04K |
|
XUNLEI SP ADS-A
BE:4XN
|
$57.98K |
|
MASTERPLAST Nyrt.
BUD:MAST
|
$57.98K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Palgon AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 151,519 to 167,871, a change of 16,352 (10.8%).
- Net income of 1,635,210 contributed positively to equity growth.
- Other factors decreased equity by 1,618,858.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.64 Million | +974.08% |
| Other Changes | €-1.62 Million | -964.34% |
| Total Change | €- | 10.79% |
Book Value vs Market Value Analysis
This analysis compares Palgon AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.62x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 7.27x to 10.62x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €0.82 | €5.94 | x |
| 2020-12-31 | €0.51 | €5.94 | x |
| 2021-12-31 | €0.56 | €5.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Palgon AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 974.08%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.07x
- Recent ROE (974.08%) is above the historical average (299.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -14.28% | 0.00% | 0.00x | 1.04x | €-59.50K |
| 2020 | -61.78% | 0.00% | 0.00x | 1.06x | €-108.76K |
| 2021 | 974.08% | 0.00% | 0.00x | 1.07x | €1.62 Million |
Industry Comparison
This section compares Palgon AG's net assets metrics with peer companies in the Consulting Services industry.
Industry Context
- Industry: Consulting Services
- Average net assets among peers: $434,077,411
- Average return on equity (ROE) among peers: -73.50%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Palgon AG (3D6) | €160.11K | -14.28% | 0.06x | $58.10K |
| Rejlerkoncernen AB (3RE) | $1.94 Billion | 11.45% | 0.91x | $278.34 Million |
| RC Fornax Plc (8AD) | $108.00K | 533.33% | 12.88x | $670.36K |
| Avemio AG (AV2) | $161.06K | -862.69% | 0.03x | $5.08K |
| Natus Medical Incorporated (NM4) | $56.82 Million | -60.23% | 2.45x | $1.95 Million |
| Ricardo plc (RIR) | $176.50 Million | 10.65% | 0.92x | $168.54 Million |